What it means
The calculation takes total research and development spending for a period and divides it by revenue for the same period. Both figures come straight from the income statement, which makes it one of the easier ratios to compare across companies.
It matters because the result is a rough proxy for how much of a company's future is being funded today. Investors in technology and life sciences often treat a falling ratio as a warning that the pipeline is being starved to protect short-term profit.
In practice the ratio is used for benchmarking against direct competitors rather than judged against an absolute target. Software businesses commonly spend 10% to 20% of revenue, industrial manufacturers nearer 3% to 5%, and consumer goods companies rather less than either.
One nuance is what actually sits inside the R&D line. Accounting rules let some development spending be capitalised as an asset rather than expensed, so a company that capitalises heavily can report a lower ratio than a competitor doing identical work.
The other nuance is that the ratio measures input, not output. Spending 18% of revenue on development says nothing about whether anything useful comes out of it, which is why analysts pair it with measures such as revenue from products launched in the last three years.
Internally, the ratio is often used as a budgeting rule rather than a reporting statistic. Setting development spending as a fixed share of revenue keeps investment moving with the size of the business and takes the annual argument out of the process.
The weakness of that approach is that it cuts research in exactly the years when a company most needs new products.
In practice
Real-world examples.
Example
A listed semiconductor firm reports an R&D to sales ratio of 22%, well above the 15% typical of its closest peers. Analysts split on whether this signals a strong pipeline or weak cost control, and press management hard on the expected payback period. Management answers by showing that 30% of current revenue comes from products launched in the last three years.
Example
A private equity owner of an industrial pumps business notices the ratio has drifted from 4% down to 1.5% over three years. The finding becomes a key point in the exit discussion, because any buyer will price in the cost of rebuilding the engineering team. Restoring spending for two years before sale is judged cheaper than accepting the discount a thin product roadmap would attract.
Example
A fast-growing software company holds R&D spending at 18% of revenue as a deliberate policy, adjusting the budget each quarter as revenue moves. Engineering leaders use the fixed percentage to plan hiring without renegotiating budget every cycle. The finance team reviews the policy annually, since a fixed share can starve development in a bad year and overfund it in a very good one.
Think of it
“R&D to sales shows what percentage of revenue you reinvest in creating future products and innovations.
Formula
Calculation
R&D to Sales Ratio = Research and Development Expense / Revenue x 100
A medical device manufacturer reports revenue of $60,000,000 for the year and research and development expense of $9,000,000.
Ratio: $9,000,000 / $60,000,000 = 0.15, or 15%
If revenue grows to $75,000,000 the following year while R&D spending is held flat at $9,000,000, the ratio falls to 12%, even though not a single dollar has been cut from the development budget.Case study
Seen in the real world.
Marlow Scientific is a fictional analytical instruments maker used here for illustrative purposes. Facing a soft year, its board cut research and development from $6,000,000 to $3,600,000, dropping the R&D to sales ratio from 12% to 7.2% on flat revenue of $50,000,000.
Profit improved immediately and the following year's results looked strong. Two years later the products Marlow would normally have launched simply did not exist, and revenue fell as competitors released newer models.
The illustrative point is that this ratio behaves like a delayed indicator: cutting it improves the current year and damages a year that is still two or three reporting cycles away. Marlow's board eventually set a floor of 10% that could only be breached with a written plan attached.
Watch out
Common mistakes.
- Comparing the ratio across industries, where a 3% figure can be generous in one sector and negligible in another.
- Ignoring how much development cost has been capitalised rather than expensed, which makes two similar companies look very different.
- Treating a high ratio as proof of innovation, when it only measures money spent and says nothing about results produced.
Questions
People also ask.
Should the denominator be revenue or gross profit?
Revenue is the standard, though businesses with very different gross margins sometimes compare R&D as a share of gross profit as well.
Does the ratio include capitalised development costs?
Usually not, since it is normally taken from the expense line, which is precisely why the capitalisation policy needs checking.
What happens to the ratio when revenue is growing fast?
It falls automatically unless spending rises in step, so a declining ratio at a fast-growing company is not necessarily a cut.
From the founder's library
Take it further with the book.
Build your financial confidence beyond this definition. Shihan's full-length guide, Accounting Fundamentals, takes the same plain-English approach and turns it into a complete, practical playbook for non-finance managers, business owners and students - with chapter-end quiz answers and presentation slides included.
25% off with code MMHQ25, applied at checkout. Priced in USD - checkout may show the equivalent in your local currency.
View the book and save 25%